Organization
Centre for Advanced Therapeutics, Mount Sinai Hospital, Toronto, Canada
1 abstract
Abstract
ADALIMUMAB INHIBITS THE PROGRESSION OF STRUCTURAL JOINT DAMAGE IN PATIENTS WITH ACTIVE RAOrg: Centre for Advanced Therapeutics, Mount Sinai Hospital, Toronto, Canada, Rheumatology Div., UCSD, La Jolla, Bainbridge Island, United States, Rheumatic Disease Centre of Montreal, Montreal, Canada, ImmunoScience Development Center, Abbott Laboratories, Parsippany, United States,